Quarterly report pursuant to Section 13 or 15(d)

Related Party Agreements (Details)

v3.22.1
Related Party Agreements (Details)
 1 Months Ended 3 Months Ended
Mar. 17, 2015
USD ($)
item
Dec. 31, 2016
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Management Services Agreement        
Related Party Transaction [Line Items]        
Number of period 5 years      
Annual consulting fee $ 500,000      
Increase in annual consulting fee 1,000,000.0      
Excess in net assets value 100,000,000      
Costs and expenses, related party     $ 125,000 $ 125,000
Fortress Biotech, Inc | Founders Agreement        
Related Party Transaction [Line Items]        
Long term debt $ 2,800,000      
Issuance of common stock, percentage of outstanding diluted equity 2.50%      
Number of business days 5 days      
Voting equity, percentage of equity or debt financing 2.50%      
Cash fee, percentage of annual net sales 4.50%      
Cash fees, maximum number of days 90 days      
Control fees, number of times | item 5      
Control fees, monthly net sales 12 months      
Cash fee, percentage of monthly net sales 4.50%      
Agreement term 15 years      
Caribe Bioadvisors LLC        
Related Party Transaction [Line Items]        
Costs and expenses, related party     $ 27,000  
Annual advisory service fee   $ 60,000    
Caribe Bioadvisors LLC | Equity Incentive Grants        
Related Party Transaction [Line Items]        
Costs and expenses, related party       $ 12,000